Regulation of IL-1 and TNF receptor expression and function by endogenous macrophage migration inhibitory factor

Journal of Immunology

Volumn 177, Issue 7, 2006, Pages 4818-4825

  Toh, Myew Ling ^a   Aeberli, Daniel ^a   Lacey, Derek ^a   Yang, Yuan ^a   Santos, Leilani L ^a   Clarkson, Michael ^a   Sharma, Laveena ^a   Clyne, Colin ^a   Morand, Eric F ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; MACROPHAGE MIGRATION INHIBITION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; IMMUNOPATHOLOGY; INFLAMMATION; MACROPHAGE MIGRATION INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SKIN FIBROBLAST; WESTERN BLOTTING;

EID: 33749153435     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.7.4818     Document Type: Article

References (59)

1. Calandra, T., and T. Roger. 2003. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 3: 791-800.
2. Lue, H., R. Kleemann, T. Calandra, T. Roger, and J. Bernhagen. 2002. Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect. 4: 449-460.
3. Leng, L., C. Metz, Y. Fang, J. Xu, S. Donnelly, J. Baugh, T. Delohery, Y. Chen, R. Mitchell, and R. Bucala. 2003. MIF signal transduction initiated by binding to CD74. J. Exp. Med. 197: 1467-1476.
4. Mitchell, R., C. Metz, T. Peng, and R. Bucala. 1999. Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF): regulatory role in cell proliferation and glucocorticoid action. J. Biol. Chem. 274: 18100-18106.
5. Liao, H., R. Bucala, and R. Mitchell. 2003. Adhesion dependent signaling by macrophage migration inhibitory factor (MIF). J. Biol. Chem. 278: 76-81.
6. Swant, J., E. Beatriz, M. Symons, and R. Mitchell. 2005. Rho GTPase-dependent signaling is required for macrophage migration inhibitory factor-mediated expression of cyclin D1. J. Biol. Chem. 280: 23066-23072.
7. Ren, Y., H. Chan, Z. Li, C. Lin, J. Nicholls, C. Chen, P. Lee, V. Lui, M. Bacher, and P. Tam. 2004. Upregulation of macrophage migration inhibitory factor contributes to induced N-myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastoma. Oncogene 23: 4146-4154.
8. Watanabe, H., T. Shimizu, J. Nishihira, R. Abe, N. Toshinori, M. Taniguchi, H. Sabe, T. Ishibashi, and H. Shimizu. 2003. Ultraviolet A-induced production of matrix mettalloproteinase-1 is mediated by macrophage migration inhibitory factor (MIF) in human dermal fibroblasts. J. Biol. Chem. 279: 1676-1683.
9. Lacey, D., A. Sampey, R. Mitchell, R. Bucala, L. Santos, M. Leech, and E. Morand. 2003. Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor. Arthritis Rheum. 48: 103-109.
10. Santos, L., D. Lacey, Y. Yang, M. Leech, and E. Morand. 2004. Activation of synovial cell p38 mitogen activated protein kinase by macrophage migration inhibitory factor. J. Rheumatol. 31: 1038-1043.
11. Onodera, S., J. Nishihira, Y. Koyama, T. Majima, Y. Aoki, H. Ichiyama, T. Ishibashi, and A. Minami. 2004. Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1β. Arthritis Rheum. 50: 1437-1447.
12. Kleemann, R., A. Hausser, G. Geiger, R. Mischke, A. Burger-Kentischer, O. Flieger, F.-J. Johannes, T. Roger, T. Calandra, A. Kapurniotu, et al. 2000. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408: 211-216.
13. Roger, T., J. David, M. Glauser, and T. Calandra. 2001. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414: 920-924.
14. Sampey, A., P. Hall, R. Mitchell, C. Metz, and E. Morand. 2001. Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor. Arthritis Rheum. 44: 1273-1280.
15. Calandra, T., J. Bernhagen, C. Metz, L. Spiegel, M. Bacher, T. Donnelly, A. Cerami, and R. Bucala. 1995. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377: 68-71.
16. Leech, M., C. Metz, P. Hall, P. Hutchinson, K. Gianis, M. Smith, H. Weedon, S. Holdsworth, R. Bucala, and E. Morand. 1999. Macrophage migration inhibitory factor (MIF) in rheumatoid arthritis: evidence for pro-inflammatory function and regulation by glucocorticoids. Arthritis Rheum. 42: 1601-1608.
17. Bozza, M., A. Satoskar, G. Lin, B. Lu, A. Humbles, C. Gerard, and J. David. 1999. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J. Exp. Med. 189: 341-346.
18. Leech, M., D. Lacey, J. Xue, L. Santos, P. Hutchinson, E. Wolvetang, J. David, R. Bucala, and E. Morand. 2003. Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis. Arthritis Rheum. 48: 1881-1889.
19. Mitchell, R., H. Liao, J. Chesney, G. Fingerle-Rowson, J. Baugh, J. David, and R. Bucala. 2002. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc. Natl. Acad. Sci. USA 99: 345-350.
20. Toh, M., Y. Yang, M. Leech, S. Santos, and E. F. Morand. 2004. Expression of MAP kinase phosphatase-1, a negative regulator of MAP kinases, in rheumatoid arthritis: upregulation by IL-1 and glucocorticoids. Arthritis Rheum. 50: 3118-3128.
21. Lacey, D., A. Sampey, R. Mitchell, R. Bucala, L. Santos, M. Leech, and E. Morand. 2003. Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor. Arthritis Rheum. 48: 103-109.
22. Pierce, J., R. Schoenleber, G. Jesmok, J. Best, S. Moore, T. Collins, and M. Gerritsen. 1997. Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem. 272: 21096-21103.
23. Yang, Y., E. Morand, S. Getting, M. Paul-Clark, D. Liu, S. Yona, R. Hannon, J. Buckingham, M. Perretti, and R. Flower. 2004. Modulation of inflammation and response to dexamethasone by annexin 1 in antigen-induced arthritis. Arthritis Rheum. 50: 976-984.
24. Overbergh, L., A. Giulietti, D. Valckx, R. Decallonne, R. Bouillon, and C. Mathieu. 2003. The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J. Biomol. Tech. 14: 33-43.
25. Vanden Berghe, W., L. Vermeulen, G. De Wilde, K. De Bosscher, E. Boone, and G. Haegeman. 2000. Signal transduction by tumour necrosis factor and gene regulation of the inflammatory cytokine interleukin-6. Biochem. Pharmacol. 60: 1185-1195.
26. Derijard, B., J. Raingeaud, T. Barrett, I. Wu, J. Han, R. Ulevitch, and R. Davis. 1995. Independent human MAP-kinase signal transduction pathways denned by MEK and MKK isoforms. Science 267: 682-685.
27. Raingeaud, J., A. Whitmarsh, T. Barrett, B. Derijard, and R. Davis. 1996. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16: 1247-1255.
28. Karin, M., and M. Delhase. 1998. JNK or IKK, AP-1 or NFκB, which are the targets for MEK kinase 1 action? Proc. Natl. Acad. Sci. USA 95: 9067-9069.
29. Schlesinger, T., G. Fanger, T. Yujin, and G. Johnson. 1998. The Tao of MEKK. Front. Biosci. 3: 1182-1186.
30. Garrington, T., and G. Johnson. 1999. Organisation and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 11: 211-218.
31. Calandra, T., J. Bernhagen, R. Mitchell, and R. Bucala. 1994. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. 179: 1895-1902.
32. Bacher, M., C. Metz, T. Calandra, K. Mayer, J. Chesney, M. Lohoff, D. Gemsa, T. Donnelly, and R. Bucala. 1996. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc. Natl. Acad. Sci. USA 93: 7849-7854.
33. Lehmann, L., S. Weher, D. Fuchs, S. Klaschik, J. Christian Schewe, M. Book, A. Hoeft, and F. Stuber. 2005. Intracellular detection of macrophage migration inhibitory factor in peripheral blood leucocytes. Free Radic. Biol. Med. 38: 1170-1179.
34. Rosengren, E., P. Aman, S. Thelin, C. Hansson, S. Ahlfors, P. Bjork, L. Jacobsson, and H. Rorsman. 1997. The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase. FEBS Lett. 417: 85-88.
35. Nguyen, M.T., J.B. Lue, H. Funfzig, R. Kleemann, P. Koolwijk, A. Kapurniotu, and J. Bernhagen. 2003. A 16-residue peptide fragment of macrophage migration inhibitory factor, MIF-(50-65), exhibits redox activity and has MIF-like biological functions. J. Biol. Chem. 278: 33654-33671.
36. Bernhagen, J., T. Calandra, R. A. Mitchell, S. B. Martin, K. J. Tracey, W. Voelter, K. R. Manogue, A. Cerami, and R. Bucala. 1993. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365: 756-759.
37. Calandra, T., L. Spiegel, C. Metz, and R. Bucala. 1998. Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. Proc. Natl. Acad. Sci. USA 95: 11383-11388.
38. Lan, H., M. Bacher, N. Yang, W. Mu, D. Nikolic-Paterson, C. Metz, A. Meinhardt, R. Bucala, and R. Atkins. 1997. The pathogenic role of macrophage migration inhibitory factor in immunoiogically induced kidney disease in the rat. J. Exp. Med 185: 1455-1465.
39. Ohkawara, T., J. Nishihira, H. Takeda, S. Hige, M. Kato, T. Sugiyama, T. Iwanaga, H. Nakamura, Y. Mizue, and M. Asaka. 2002. Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice. Gastroenterology 123: 256-270.
40. Onodera, S., K. Kaneda, Y. Mizue, Y. Koyama, M. Fujinaga, and J. Nishihira. 2000. Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. J. Biol. Chem. 275: 444-450.
41. Onodera, S., J. Nishihira, K. Iwabuchi, Y. Koyami, K. Yoshida, S. Tanaka, and A. Minami. 2001. Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and -13 in rat osteoblasts: relevance to intracelluiar signaling pathways. J. Biol. Chem. 277: 7865-7874.
42. Mitchell, R. 2004. Mechanisms and effectors of MIF-dependent promotion of tumourigenesis. Cell Signal 16: 13-19.
43. Takahashi, N., J. Nishihira, Y. Sato, M. Kondo, H. Ogawa, T. Ohshima, Y. Une, and S. Todo. 1998. Involvement of macrophage migration inhibitory factor in the mechanism of tumour cell growth. Mol. Med. 4: 707-714.
44. Onodera, S., J. Nishihira, Y. Koyama, T. Majima, Y. Aoki, H. Ichiyama, T. Ishibashi, and A. Minami. 2004. Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1β. Arthritis Rheum. 50: 1437-1447.
45. Daun, J., and J. Cannon. 2000. Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IκBα. Am. J. Physiol. 279: R1043-R1049.
46. Kleemann, R., A. Hausser, G. Geiger, R. Mischke, A. Burger-Kentischer, O. Flieger, F. J. Johannes, T. Roger, T. Calandra, A. Kapurniotu, et al. 2000. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408: 211-216.
47. Georganas, C., H. Liu, H. Perlman, A. Hoffmann, B. Thimmapaya, and R. Pope. 2000. Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: the dominant role for NF-κB but not C/EBPβ or c-Jun. J. Immunol. 165: 7199-7206.
48. Satoskar, A., M. Bozza, M. Rodiguez Sosa, G. Lin, and J. David. 2001. Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection. Infect. Immun. 69: 906-911.
49. Dunne, A., and L. O'Neill. 2003. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci. STKE 171: re3.
50. Ye, K., C. Dinarello, and B. Clark. 1993. Identification of the promoter region of human interleukin 1 type 1 receptor gene: multiple initiation sites, high G+C content, and constitutive expression. Proc. Natl. Acad. Sci. USA 90: 2295-2299.
51. Lloberas, J., C. Soler, and A. Celada. 1999. The key roleof PU.1/SPI-1 in B cells, myeloid cells and macrophages. Immunol. Today 20: 184-189.
52. Liz-Grana, M., and J. Gomez-Reino Carnota. 2001. Tumour necrosis factor: genetics, cell action mechanism and involvement in inflammation. Allergy Immunol. Clin. 16: 140-149.
53. Chen, G., and D. Goeddel. 2002. TNF-R1 signaling: a beautiful pathway. Science 296: 1634-1635.
54. Leo, E., K. Welsh, S. Matsuzawa, J. Zapata, S. Kitada, R. Mitchell, K. Ely, and J. Reed. 1999. Differential requirements of tumour necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-κB and jun N-terminal kinase activation. J. Biol. Chem. 274: 22414-22422.
55. 1 protein signaling pathways regulate extracellular signal-regulated kinase phosphorylation and AP-1 activation independent of NFκB activation. Shock 22: 57-62.
56. Cottin, V., A. Van Linden, and D. Riches. 2001. Phosphorylation of the tumour necrosis factor receptor CD 120a (p55) recruits Bcl-2 and protects against apoptosis. J. Biol. Chem. 276: 17252-17260.
57. maPk/erk2 activation, but not NF-κB activation. J. Immunol. 172: 7654-7660.
58. Habelhah, H., S. Takahashi, S. Cho, T. Kadoya, T. Watanabe, and Z. Ronai. 2004. Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-κB. EMBO J. 23: 322-332.
59. Yeh, W., A. Shahinian, D. Speiser, J. Kraunus, F. Billia, A. Wakeham, J. de la Pompa, D. Ferrick, B. Hum, N. Iscove, et al. 1997. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7: 715-725.